We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$1.33B
AUM Growth
+$165M
Cap. Flow
+$79.5M
Cap. Flow %
5.97%
Top 10 Hldgs %
31.77%
Holding
2,605
New
162
Increased
932
Reduced
550
Closed
151

Sector Composition

Rank Sector Weight
1 Technology 11.86%
2 Financials 5.93%
3 Healthcare 5.52%
4 Communication Services 4.11%
5 Consumer Discretionary 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THG icon
651
Hanover Insurance
THG
$7.98B
$135K 0.01%
986
+40
+4% +$5.38K
VDC icon
652
Vanguard Consumer Staples ETF
VDC
$7.97B
$135K 0.01%
838
-24
-3% -$3.77K
DTE icon
653
DTE Energy
DTE
$29.1B
$134K 0.01%
1,209
-60
-5% -$6.47K
QGEN icon
654
Qiagen
QGEN
$8.72B
$134K 0.01%
3,736
-84
-2% -$3.12K
RPD icon
655
Rapid7
RPD
$773M
$134K 0.01%
2,400
ISTB icon
656
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
$133K 0.01%
2,645
+3
+0.1% +$151
PCAR icon
657
PACCAR
PCAR
$70.1B
$133K 0.01%
2,522
-105
-4% -$5.4K
VFH icon
658
Vanguard Financials ETF
VFH
$13.8B
$133K 0.01%
1,740
+137
+9% +$10K
GNTX icon
659
Gentex
GNTX
$5.07B
$132K 0.01%
4,547
+23
+0.5% +$648
REGN icon
660
Regeneron Pharmaceuticals
REGN
$80.8B
$132K 0.01%
351
+73
+26% +$24.6K
SPLK
661
DELISTED
Splunk Inc
SPLK
$132K 0.01%
882
-6
-0.7% -$788
XLNX
662
DELISTED
Xilinx Inc
XLNX
$132K 0.01%
1,347
+463
+52% +$43.5K
PTLA
663
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$132K 0.01%
5,536
-655
-11% -$18.1K
RCL icon
664
Royal Caribbean
RCL
$85.6B
$131K 0.01%
984
+54
+6% +$6.29K
CSFL
665
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$131K 0.01%
5,252
DBC icon
666
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$130K 0.01%
8,140
-4,040
-33% -$62.7K
GVI icon
667
iShares Intermediate Government/Credit Bond ETF
GVI
$3.8B
$130K 0.01%
1,152
MNST icon
668
Monster Beverage
MNST
$88.5B
$130K 0.01%
4,090
-830
-17% -$24.4K
SAM icon
669
Boston Beer
SAM
$1.92B
$130K 0.01%
345
-36
-9% -$13.6K
TDG icon
670
TransDigm Group
TDG
$67.7B
$130K 0.01%
233
+98
+73% +$53.6K
CE icon
671
Celanese
CE
$4.82B
$129K 0.01%
1,051
-222
-17% -$27.3K
ENB icon
672
Enbridge
ENB
$112B
$129K 0.01%
3,243
-2,474
-43% -$92.4K
GSK icon
673
GSK
GSK
$106B
$129K 0.01%
2,188
-318
-13% -$17.7K
LUMN icon
674
Lumen
LUMN
$6.44B
$129K 0.01%
9,764
-1,159
-11% -$15.5K
LVS icon
675
Las Vegas Sands
LVS
$29.6B
$129K 0.01%
1,864
+470
+34% +$29.3K

Similar funds

Parallel Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Parallel Advisors held 2,605 positions worth $1.33B, up 14% from $1.17B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors deployed $79.5M of net new capital in Q4 2019, opening 162 new positions and adding to 932 existing holdings. Its largest new stake was iShares MSCI USA Size Factor ETF: 115,543 shares worth $11.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $4.58M trimmed.

  • Parallel Advisors's largest Q4 2019 buy was iShares MSCI USA Size Factor ETF: 115,543 shares worth $11.3M.
  • Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q4 2019, an estimated $19.3M increase.
  • Parallel Advisors's biggest Q4 2019 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $4.58M.
  • Parallel Advisors fully exited Onto Innovation in Q4 2019, selling an estimated $6.7M.
  • Parallel Advisors's ten largest holdings make up 32% of its $1.33B portfolio in Q4 2019.
  • Parallel Advisors opened 162 new positions and closed 151 in Q4 2019.
  • Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.33B.

Based on Parallel Advisors's 13F filing for Q4 2019, filed 30 Jan 2020.